iBio Inc. – Filings and Transcripts

NASDAQ: IBIO
Share price (9/29/26): $1.17
Market cap (9/29/26): $75.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 FY 2026

ended 03/31/26 Q3

ended 12/31/25 Q2

ended 09/30/25 Q1 2026 – amended

ended 09/30/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement

Shelf registration

Ownership Filter

Cormorant Asset Management, LP

Lynx1 Capital Management LP

Vestal Point Capital, LP

Affinity Asset Advisors, LLC

News Filter

Investor Presentation

Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Strengthens Clinical Leadership With Appointment of Endocrinologist Molly Carr as Chief Medical Officer

Shareholder Nominations, Other Events, Financial Statements or Exhibits

Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness